Cannabis use linked to nearly 4x higher lung cancer risk

Association of cannabis use and lung cancer: a retrospective cohort study.

Lung cancer (Amsterdam, Netherlands) • • Moderately Relevant
🤖

AI Summary

This retrospective cohort study analyzed 20 years of medical records from over 300,000 patients across 67 U.S. healthcare organizations to examine whether heavy cannabis use increases lung cancer risk. Researchers compared 149,632 individuals with cannabis use disorder to a matched comparison group without cannabis use disorder, controlling for smoking status and other risk factors. The findings were striking: people with cannabis use disorder showed a 3.87-fold increased risk of developing lung or bronchus cancer compared to those without cannabis use disorder, with risks remaining elevated at both one and five-year follow-ups.

The elevated risk appeared across all lung cancer types examined, including small cell carcinoma (2.70-fold increase), adenocarcinoma (2.54-fold increase), and squamous cell carcinoma (2.90-fold increase). This consistency across different cancer subtypes suggests a robust association rather than a chance finding. The study controlled for traditional risk factors like smoking history, meaning the increased risk was observed even after accounting for potential confounding factors that might explain the association.

Given the growing legalization and use of cannabis in many regions, these findings carry important public health implications. The researchers emphasize that further investigation is needed to understand dose-response relationships and the biological mechanisms linking cannabis use to lung cancer risk. Clinicians are advised to discuss these potential risks with patients considering cannabis use, particularly heavy or long-term use patterns. The study highlights a critical gap in our understanding of cannabis's health effects and underscores the importance of continued research as cannabis use becomes more common.

📄 Original Abstract

Lung cancer is the leading cause of cancer-related mortality globally, largely driven by smoking. This study seeks to determine if heavy cannabis use is associated with an increased risk of cancer of the lung and bronchus. This is a retrospective cohort study utilizing 20 years of deidentified electronic medical record data from 67 tertiary healthcare organizations across the United States. Cohorts included adults (≥18 years) diagnosed with cannabis use disorder and a comparison group without cannabis use disorder. Relative risk for development of new cancer of the lung and/or bronchus was analyzed after propensity score matching between groups based on demographics and risk factors for development of lung cancer (n = 149,632 per group). After matching, individuals with cannabis use disorder demonstrated a significantly higher risk of developing lung and/or bronchus cancer compared to those without cannabis use disorder (RR 3.87, 95% CI 3.43-4.38). The risk remained elevated after one and five years of follow-up. A specific increased risk was found for all histologic subtypes analyzed, including small cell carcinoma (RR 2.70, 95% CI 1.31-5.58), adenocarcinoma (RR 2.54, 95% CI 1.59-4.08), and squamous cell carcinoma (RR 2.90, 95% CI 1.41-5.95). These findings suggest that heavy cannabis use is significantly associated with an increased risk of lung cancer. Given the rising prevalence of cannabis use, further research is needed to clarify dose-response relationships and the biological mechanisms driving these associations. Clinicians should consider these risks when advising patients about cannabis use.

Explore More Research

Stay informed about the latest cannabis science.

Your stash, decoded.